Dr. David B Beeson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4781 Kaybee Dr, Gas City, IN 46933 Phone: 765-998-9980 Fax: 765-998-9984 |
News Archive
China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its unaudited financial results for the fourth quarter and full year 2011.
A study released today in JAMA Network Open reported that smoking after a cancer diagnosis is associated with substantial additional costs of cancer treatment.
A year after its launch, the first dermatologist-driven company dedicated to primary skin cancer protection and prevention introduced its newest solar protection product - a much-anticipated tinted mineral gel sunscreen – at the 2011 AAD meeting in New Orleans.
Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.
› Verified 2 days ago